Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma

Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma

Background: Lower-grade gliomas (LGGs) are a heterogeneous set of gliomas. One of the primary sources of glioma heterogeneity is genomic instability, a novel characteristic of cancer. It has been reported that long noncoding RNAs (lncRNAs) play an essential role in regulating genomic stability. Howe...

Full description

Bibliographic Details
Main Authors:	Yudong Cao, Hecheng Zhu, Weidong Liu, Lei Wang, Wen Yin, Jun Tan, Quanwei Zhou, Zhaoqi Xin, Hailong Huang, Dongcheng Xie, Ming Zhao, Xingjun Jiang, Jiahui Peng, Caiping Ren
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Genetics
Subjects:	genome instability lower-grade glioma multi-omics analysis long noncoding RNA signature
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2021.758596/full

Similar Items

Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma
by: Yudong Cao, et al.
Published: (2022-08-01)

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
by: Yi Zhou, et al.
Published: (2023-11-01)

Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma
by: Yao Zhou, et al.
Published: (2023-12-01)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
by: Yudong Cao, et al.
Published: (2021-06-01)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
by: Wen Yin, et al.
Published: (2020-08-01)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
by: Hongbo Zhang, et al.
Published: (2020-12-01)

Identification and Validation of a Seizure-Free-Related Gene Signature for Predicting Poor Prognosis in Lower-Grade Gliomas
by: Li J, et al.
Published: (2021-10-01)

Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
by: Wen-Jing Zeng, et al.
Published: (2018-05-01)

Comparative profiling of immune genes improves the prognoses of lower grade gliomas
by: Zhiliang Wang, et al.
Published: (2022-04-01)

Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
by: Qiang Zhang, et al.
Published: (2021-07-01)

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients
by: Jun Tan, et al.
Published: (2021-03-01)

Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes
by: Junsheng Li, et al.
Published: (2022-10-01)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
by: Qian-Rong Huang, et al.
Published: (2022-06-01)

DeepAutoGlioma: a deep learning autoencoder-based multi-omics data integration and classification tools for glioma subtyping
by: Sana Munquad, et al.
Published: (2023-11-01)

A Novel Six Autophagy-Related Genes Signature Associated With Outcomes and Immune Microenvironment in Lower-Grade Glioma
by: Tao Lin, et al.
Published: (2021-10-01)

Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
by: Yirui Kuang, et al.
Published: (2023-04-01)

Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients
by: Jin-Cheng Guo, et al.
Published: (2021-03-01)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
by: Xiangyang Deng, et al.
Published: (2019-11-01)

A Radiomics-Based Machine Learning Model for Prediction of Tumor Mutational Burden in Lower-Grade Gliomas
by: Luu Ho Thanh Lam, et al.
Published: (2022-07-01)

Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma
by: Junsheng Zhao, et al.
Published: (2021-11-01)

Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas
by: Rui Tao, et al.
Published: (2023-07-01)

Genomic instability in lower-grade glioma: Prediction of prognosis based on lncRNA and immune infiltration
by: Kai Kang, et al.
Published: (2021-09-01)

Cuproptosis-related gene signature stratifies lower-grade glioma patients and predicts immune characteristics
by: Zihao Zhang, et al.
Published: (2022-10-01)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
by: Mingwei Zhang, et al.
Published: (2020-04-01)

Staged resection of multilobar lower-grade glioma: Case report and review of the literature
by: Ronald Sahyouni, et al.
Published: (2022-06-01)

Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma
by: Jie Wang, et al.
Published: (2022-09-01)

The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma
by: Yungang Hu, et al.
Published: (2023-04-01)

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
by: Liguo Ye, et al.
Published: (2021-10-01)

Identification and Validation of a Novel Three Hub Long Noncoding RNAs With m6A Modification Signature in Low-Grade Gliomas
by: Quang-Huy Nguyen, et al.
Published: (2022-02-01)

Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma
by: Mingwei Zhang, et al.
Published: (2020-05-01)

Transcriptional Networks Identify BRPF1 as a Potential Drug Target Based on Inflammatory Signature in Primary Lower-Grade Gliomas
by: Mingyang Xia, et al.
Published: (2021-12-01)

Integrated profiling identifies ferredoxin 1 as an immune-related biomarker of malignant phenotype in glioma
by: Dongcheng Xie, et al.
Published: (2024-03-01)

Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma
by: Huihan Yu, et al.
Published: (2022-08-01)

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
by: Zhipeng Jiang, et al.
Published: (2021-07-01)

Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma
by: Zhaoping Wu, et al.
Published: (2023-03-01)

Identification of potential biomarkers related to glioma survival by gene expression profile analysis
by: Justin Bo-Kai Hsu, et al.
Published: (2019-03-01)

A novel prognostic 7-methylguanosine signature reflects immune microenvironment and alternative splicing in glioma based on multi-omics analysis
by: Zihan Wang, et al.
Published: (2022-08-01)

An automated approach for predicting glioma grade and survival of LGG patients using CNN and radiomics
by: Chenan Xu, et al.
Published: (2022-08-01)

Comprehensive analyses of m1A regulator-mediated modification patterns determining prognosis in lower-grade glioma (running title: m1A in LGG)
by: Kunjian Lei, et al.
Published: (2024-03-01)

Comprehensive analysis of genes based on chr1p/19q co-deletion reveals a robust 4-gene prognostic signature for lower grade glioma
by: Zhang C, et al.
Published: (2019-05-01)